- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about PFE
Recent news which mentions PFE
2 Magnificent Stocks to Buy That Are Near 52-Week Lows
November 05, 2024
From Motley Fool
Is Pfizer Stock a Bargain for Long-Term Investors?
November 04, 2024
From Motley Fool
2 Sensational Growth Stocks to Buy at a Discount
November 03, 2024
From Motley Fool
This Beaten-Down Stock Just Gave Investors More Good News: Is it a Buy?
November 03, 2024
Tickers
PFE
From Motley Fool
3 Potential Catalysts That Could Lift Pfizer Stock Before 2025
November 03, 2024
Tickers
PFE
From Motley Fool
3 Reasons Relying on Social Security Alone Could be a Risk. And 3 Stocks to Invest in Today.
November 01, 2024
From Motley Fool
Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy
November 01, 2024
From Benzinga
Tickers
PFE
From Motley Fool
Nasdaq Hits Record High Ahead Of Big Tech Earnings: Fear Index Remains In 'Greed' Zone
October 30, 2024
From Benzinga
Tech Stocks Rise Ahead Of Key Earnings, Gold Smashes Records, Bitcoin Nears All-Time Highs: What's Driving Markets Tuesday?
October 29, 2024
From Benzinga
Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views
October 29, 2024
From Benzinga
Pfizer Q3 Earnings: Revenue And Profit Beat On Heightened Demand For Paxlovid, Expects $10 Billion In 2024 Revenue From COVID Products
October 29, 2024
From Benzinga
From Benzinga
Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
October 29, 2024
From Benzinga
Pfizer, Alphabet And 3 Stocks To Watch Heading Into Tuesday
October 29, 2024
From Benzinga
Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
October 28, 2024
From Benzinga
These 7 Blunt Words Just Opened a Can of Worms For Pfizer's Stock
October 27, 2024
Tickers
PFE
From Motley Fool
3 Magnificent S&P 500 Dividend Stocks Down 43%, 20%, and 53% to Buy and Hold Forever
October 26, 2024
From Motley Fool
3 Spooky Signs That You're About to Lose Your Money on a Healthcare Stock Investment
October 26, 2024
From Motley Fool
Pfizer, Live Nation Entertainment And More On CNBC's 'Final Trades'
October 25, 2024
From Benzinga
Got $1,000? 2 Healthcare Stocks to Buy and Hold Forever.
October 25, 2024
From Motley Fool
3 Sweet Dividend Stocks to Treat Your Portfolio With This Halloween
October 25, 2024
From Motley Fool
Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population
October 24, 2024
From Benzinga
CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines
October 24, 2024
From Benzinga
5 High-Yield Dividend Stocks to Buy Without Hesitation
October 24, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.